| AstraZeneca AG - Synagis 50 mg/0.5 ml, Injektionslösung |
| 65695 | | 01 | | Synagis 50 mg/0.5 ml | | Injektionslösung | | J06BD01 | | | | 05.07.2016 | | |
|
| Composition |
| palivizumabum 50 mg, histidinum, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Palivizumab | 50mg / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| Palivizumab | 50 mg |
| | | | Inactive agents |
|---|
| Glycin | | Histidine |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 558.68 | 624.00 | A | SL | Yes |
|
